help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maison, P.
Right arrow Articles by Chanson, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maison, P.
Right arrow Articles by Chanson, P.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 5 2192-2199
Copyright © 2004 by The Endocrine Society

Impact of Growth Hormone (GH) Treatment on Cardiovascular Risk Factors in GH-Deficient Adults: A Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials

Patrick Maison, Simon Griffin, Marc Nicoue-Beglah, Nabila Haddad, Beverley Balkau and Philippe Chanson

Clinical Pharmacology (P.M.), Clinical Research Unit, Assistance Pubique-Hôpitaux de Paris, Henri Mondor University Hospital, F-94010 Créteil, France; Institut National de la Santé et de la Recherche Médicale U258 (P.M., M.N.-B., N.H., B.B.), F-94807 Villejuif, France; Institute of Public Health (S.G.), CB2 2SR Cambridge, United Kingdom; and Endocrinology and Reproductive Diseases (P.C.), Assistance Publique-Hôpitaux de Paris, Bicêtre University Hospital, and University Paris XI, F-94275 Le Kremlin-Bicêtre, France

Address all correspondence and requests for reprints to: P. Chanson, M.D., Endocrinology, Bicêtre University Hospital, 78 rue du Général Leclerc, F-94275 Le Kremlin-Bicêtre, France. E-mail: philippe.chanson{at}bct.ap-hop-paris.fr.

Patients with hypopituitarism have an increased risk of cardiovascular mortality. GH treatment could modify the cardiovascular risk in adults with GH deficiency, but most published clinical trials involved few patients and the results are variable.

We conducted a systematic review of blinded, randomized, placebo-controlled trials of GH treatment in adult patients with GH deficiency published up to August 2003. Thirty-seven trials were identified. We combined the results for effects on lean and fat body mass; body mass index; triglyceride and cholesterol [high-density lipoprotein, low-density lipoprotein (LDL), and total] levels; blood pressure; glycemia; and insulinemia. Overall effect size was used to evaluate significance, and weighted differences between GH and placebo were used to appreciate the size of the effect.

GH treatment significantly reduced LDL cholesterol [–0.5 (SD 0.3) mmol/liter], total cholesterol [–0.3 (0.3) mmol/liter], fat mass [–3.1 (3.3) kg], and diastolic blood pressure [–1.8 (3.8) mm Hg] and significantly increased lean body mass [+2.7 (2.6) kg], fasting plasma glucose [+0.2 (0.1) mmol/liter], and insulin [+8.7 (7.0) pmol/liter]. All effect sizes remained significant in trials with low doses and long-duration GH treatment.

Thus, GH treatment has beneficial effects on lean and fat body mass, total and LDL cholesterol levels, and diastolic blood pressure but reduces insulin sensitivity. The global cardiovascular benefit remains to be determined in large trials with appropriate clinical endpoints.

Abbreviations: BMI, Body mass index; GHD, GH deficiency; LDL, low-density lipoprotein.




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
J. Svensson and B.-A. Bengtsson
Safety aspects of GH replacement
Eur. J. Endocrinol., November 1, 2009; 161(S1): S65 - S74.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. Verhelst and R. Abs
Cardiovascular risk factors in hypopituitary GH-deficient adults
Eur. J. Endocrinol., November 1, 2009; 161(S1): S41 - S49.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. A. Bredella, M. Torriani, B. J. Thomas, R. H. Ghomi, D. J. Brick, A. V. Gerweck, and K. K. Miller
Peak Growth Hormone-Releasing Hormone-Arginine-Stimulated Growth Hormone Is Inversely Associated with Intramyocellular and Intrahepatic Lipid Content in Premenopausal Women with Obesity
J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3995 - 4002.
[Abstract] [Full Text] [PDF]

Home page
 Lab MedHome page
C. Chisholm, M. Spiekerman, and W. Koss
Undetectable Prostate-Specific Antigen in the Absence of Previous Prostatectomy: Laboratory Error or True Finding?
Lab Med, August 1, 2009; 40(8): 466 - 469.
[Full Text] [PDF]

Home page
 Endocr. Rev.Home page
N. Moller and J. O. L. Jorgensen
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Endocr. Rev., April 1, 2009; 30(2): 152 - 177.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Colao, C. Di Somma, S. Spiezia, S. Savastano, F. Rota, M. C. Savanelli, and G. Lombardi
Growth Hormone Treatment on Atherosclerosis: Results of a 5-Year Open, Prospective, Controlled Study in Male Patients with Severe Growth Hormone Deficiency
J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3416 - 3424.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. A van der Klaauw, A. M Pereira, T. J Rabelink, E. P M Corssmit, A.-J. Zonneveld, H. Pijl, H. C de Boer, J. W A Smit, J. A Romijn, and E. J P de Koning
Recombinant human GH replacement increases CD34+ cells and improves endothelial function in adults with GH deficiency
Eur. J. Endocrinol., August 1, 2008; 159(2): 105 - 111.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. A. van der Klaauw, T. van der Straaten, R. Baak-Pablo, N. R. Biermasz, H.-J. Guchelaar, A. M. Pereira, J. W. A. Smit, and J. A. Romijn
Influence of the d3-Growth Hormone (GH) Receptor Isoform on Short-Term and Long-Term Treatment Response to GH Replacement in GH-Deficient Adults
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2828 - 2834.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. L. Utz, A. Yamamoto, L. Hemphill, and K. K. Miller
Growth Hormone Deficiency by Growth Hormone Releasing Hormone-Arginine Testing Criteria Predicts Increased Cardiovascular Risk Markers in Normal Young Overweight and Obese Women
J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2507 - 2514.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Beauregard, A. L. Utz, A. E. Schaub, L. Nachtigall, B. M. K. Biller, K. K. Miller, and A. Klibanski
Growth Hormone Decreases Visceral Fat and Improves Cardiovascular Risk Markers in Women with Hypopituitarism: A Randomized, Placebo-Controlled Study
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2063 - 2071.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. L. M. Oliveira, M. H. Aguiar-Oliveira, A. D'Oliveira Jr, R. M. C. Pereira, C. R. P. Oliveira, C. T. Farias, J. A. Barreto-Filho, F. D. Anjos-Andrade, C. Marques-Santos, A. C. Nascimento-Junior, et al.
Congenital Growth Hormone (GH) Deficiency and Atherosclerosis: Effects of GH Replacement in GH-Naive Adults
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4664 - 4670.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Slawik, B. Klawitter, E. Meiser, M. Schories, O. Zwermann, K. Borm, M. Peper, B. Lubrich, M. J. Hug, M. Nauck, et al.
Thyroid Hormone Replacement for Central Hypothyroidism: A Randomized Controlled Trial Comparing Two Doses of Thyroxine (T4) with a Combination of T4 and Triiodothyronine
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4115 - 4122.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Holmer, J. Svensson, L. Rylander, G. Johannsson, T. Rosen, B.-A. Bengtsson, M. Thoren, C. Hoybye, M. Degerblad, M. Bramnert, et al.
Nonfatal Stroke, Cardiac Disease, and Diabetes Mellitus in Hypopituitary Patients on Hormone Replacement Including Growth Hormone
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3560 - 3567.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A. A van der Klaauw, N. R Biermasz, E. J M Feskens, M. B Bos, J. W A Smit, F. Roelfsema, E. P M Corssmit, H. Pijl, J. A Romijn, and A. M Pereira
The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH
Eur. J. Endocrinol., April 1, 2007; 156(4): 455 - 462.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
M. Rizzo, R. Trepp, K. Berneis, and E. R Christ
Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy
Eur. J. Endocrinol., March 1, 2007; 156(3): 361 - 367.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Le Corvoisier, L. Hittinger, P. Chanson, O. Montagne, I. Macquin-Mavier, and P. Maison
Cardiac Effects of Growth Hormone Treatment in Chronic Heart Failure: A Meta-Analysis
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 180 - 185.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
A A van der Klaauw, J A Romijn, N R Biermasz, J W A Smit, J van Doorn, O M Dekkers, F Roelfsema, and A M Pereira
Sustained effects of recombinant GH replacement after 7 years of treatment in adults with GH deficiency.
Eur. J. Endocrinol., November 1, 2006; 155(5): 701 - 708.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
R. Abs, U. Feldt-Rasmussen, A. F Mattsson, J. P Monson, B.-A. Bengtsson, M. I Goth, P. Wilton, and M. Koltowska-Haggstrom
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.
Eur. J. Endocrinol., July 1, 2006; 155(1): 79 - 90.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. L. Menezes Oliveira, C. Marques-Santos, J. A. Barreto-Filho, R. Ximenes Filho, A. V. de Oliveira Britto, A. H. Oliveira Souza, C. M. Prado, C. R. Pereira Oliveira, R. M. C. Pereira, T. de Almeida Ribeiro Vicente, et al.
Lack of Evidence of Premature Atherosclerosis in Untreated Severe Isolated Growth Hormone (GH) Deficiency due to a GH-Releasing Hormone Receptor Mutation
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2093 - 2099.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Wei, Z. Rhani, and C. G. Goodyer
Characterization of Growth Hormone Receptor Messenger Ribonucleic Acid Variants in Human Adipocytes
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1901 - 1908.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. E. Molitch, D. R. Clemmons, S. Malozowski, G. R. Merriam, S. M. Shalet, M. L. Vance, and for The Endocrine Society's Clinical Guidelines Su
Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1621 - 1634.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
A. Baessler, A. E. Kwitek, M. Fischer, M. Koehler, W. Reinhard, J. Erdmann, G. Riegger, A. Doering, H. Schunkert, and C. Hengstenberg
Association of the Ghrelin Receptor Gene Region With Left Ventricular Hypertrophy in the General Population: Results of the MONICA/KORA Augsburg Echocardiographic Substudy
Hypertension, May 1, 2006; 47(5): 920 - 927.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. Bollerslev, T. Ueland, A. P Jorgensen, K. J Fougner, R. Wergeland, T. Schreiner, and P. Burman
Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency.
Eur. J. Endocrinol., April 1, 2006; 154(4): 537 - 543.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. K. Paulsen, S. B. Pedersen, J. O. L. Jorgensen, S. Fisker, J. S. Christiansen, A. Flyvbjerg, and B. Richelsen
Growth Hormone (GH) Substitution in GH-Deficient Patients Inhibits 11{beta}-Hydroxysteroid Dehydrogenase Type 1 Messenger Ribonucleic Acid Expression in Adipose Tissue
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1093 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. R. Hoffman, B. M. K. Biller, D. Cook, J. Baptista, B. L. Silverman, L. Dao, K. M. Attie, P. Fielder, T. Maneatis, B. Lippe, et al.
Efficacy of a Long-Acting Growth Hormone (GH) Preparation in Patients with Adult GH Deficiency
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6431 - 6440.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. Bollerslev, J. Hallen, K. J Fougner, A. P. Jorgensen, C. Kristo, H. Fagertun, O. Gudmundsen, P. Burman, and T. Schreiner
Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial
Eur. J. Endocrinol., September 1, 2005; 153(3): 379 - 387.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Colao, C. Di Somma, A. Cuocolo, L. Spinelli, W. Acampa, S. Spiezia, F. Rota, M. C. Savanelli, and G. Lombardi
Does a Gender-Related Effect of Growth Hormone (GH) Replacement Exist on Cardiovascular Risk Factors, Cardiac Morphology, and Performance and Atherosclerosis? Results of a Two-Year Open, Prospective Study in Young Adult Men and Women with Severe GH Deficiency
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5146 - 5155.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
K. Chihara, E. Koledova, A. Shimatsu, Y. Kato, H. Kohno, T. Tanaka, A. Teramoto, P. C Bates, and A. F Attanasio
An individualized GH dose regimen for long-term GH treatment in Japanese patients with adult GH deficiency
Eur. J. Endocrinol., July 1, 2005; 153(1): 57 - 65.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Gola, S. Bonadonna, M. Doga, and A. Giustina
Growth Hormone and Cardiovascular Risk Factors
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1864 - 1870.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society